HOME >> MEDICINE >> NEWS
Fred Hutchinson Research Center awarded $7 million grant

WHITE PLAINS, N.Y. (October 2, 2002) - The Leukemia & Lymphoma Society (the Society) announced it has awarded a $7 million grant through its Specialized Center of Research (SCOR) program to Dr. Irwin Bernstein, head of pediatric oncology research at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Bernstein will accept the award in Washington, D.C. at the Society's Journey of Hope Research Award Dinner tomorrow night. The dinner will to be hosted by ABC News veteran Sam Donaldson.

SCOR is the Society's most ambitious research program and one of the largest coordinated efforts to combat leukemia, lymphoma, myeloma and Hodgkin's disease with funding that rivals federal support for blood cancers. Through SCOR grants, teams of researchers representing different disciplines focus on improving the treatment and diagnosis of blood cancers.

The research initiative, conducted by Dr. Bernstein and a team of internationally recognized researchers, is aimed at developing less toxic and more effective immune-based therapies for treating advanced leukemia and lymphoma. The researchers will attempt to harness immune cells and antibodies to selectively kill cancerous cells. In addition to Dr. Bernstein, who pioneered monoclonal antibody therapy for leukemia as well as the development, with Wyeth-Ayerst, of a monoclonal drug conjugate known as Mylotarg, the research team includes scientists from Fred Hutchinson and the University of Washington Academic Medical Center: Dr. Rainer Storb, head of transplantation biology at Fred Hutchinson and pioneer of non-myeloablative stem-cell transplantation (mini transplants) also one of the researchers who developed bone-marrow transplantation. Drs. Philip Greenberg, head of immunology at Fred Hutchinson, and Stanley Riddell, discoverers of a technique known as Rapid Expansion Method (REM), the technology used to expand antigen-specific T cells for use in adoptive immunotherapy techniques. Dr. Oliver Press, int
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
2-Oct-2002


Page: 1 2 3

Related medicine news :

1. Fred Hutchinson receives $9.7 million to lead early detection consortium
2. Fred Hutchinson uses IBM technology to help find genetic links to immune-system diseases
3. Fred Hutchinson Cancer Research Center study shows retinoids kill childhood brain tumor cells
4. Fred Hutchinson oversees two grants of nearly $8 million to develop blood test for breast cancer
5. Fred Hutchinson receives $12.7 million to lead prostate-cancer consortium
6. Hutchinson Center receives $1.2 million from National Science Foundation to study plant genetics
7. Of vasectomies, vitamins and prostate-cancer risk: Hutchinson Center study examines the links
8. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
9. Researchers search for first sign of congestive heart failure
10. Research offers hope of new treatments for liver damage
11. Research suggests possible blood test for multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fred Hutchinson Research Center awarded million grant

(Date:4/21/2015)... 2015 Carinsurancesavings.biz has released a new blog ... surveillance and explaining the impact on a uto insurance ... and supervised may be eligible for advantageous auto insurance discounts. ... simple and efficient way. This will also help them get ... simple way. , Finding low cost coverage is no longer ...
(Date:4/21/2015)... 2015 Optimity Advisors ( Optimity), ... firm that helps clients in complex industries navigate ... the Association of Community Affiliated Plans ... represents 58 local, not-for-profit, community-affiliated Safety Net Health ... people primarily enrolled in public or state-sponsored coverage ...
(Date:4/21/2015)... CO (PRWEB) April 21, 2015 ... Management , a new knowledge management solution that ... and publishing of policies and procedures. With Quark ... create reusable content that is easy to save, ... is susceptible to risk and compliance issues. Examples ...
(Date:4/21/2015)... When a bandage sticks to an injury ... to solve this problem two inventors from Festus, Mo., ... bandage helps a cut, burn, abrasion or wound heal ... exposure. The bandage is easy to use, versatile and ... submitted to the St. Louis office of InventHelp. It ...
(Date:4/21/2015)... Ill. (PRWEB) April 21, 2015 The ... the late cosmetic dermatologist Fredric S. Brandt, M.D., by ... Dr. Brandt, an ASDS member since 1982, died earlier ... The funds are designed to provide opportunities for ASDS ... field of cosmetic dermatology that Dr. Brandt held so ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4
(Date:4/21/2015)... 21, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that the abstract describing ... from the Phase 2 clinical trial of the Company,s ... selected for an oral presentation at the 2015 American ... held in Chicago, Illinois May ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... Ireland , April 20, 2015 ... that Charles M. Mayr , Chief Communications ... due to health reasons.  In conjunction with Mayr,s ... will assume the role of Chief Communications Officer, ... Kelly served as Senior Vice President, Chief Communications ...
Breaking Medicine Technology:Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
Cached News: